January 2008 - February 2008
The
Hot Topics in the Management of Atopic Dermatitis—Web-Based Teleconference Series invites dermatologists to "meet the experts" and participate in a live discussion of diagnostic and treatment issues involved in the treatment of steroid-responsive dermatitis among key patient populations.
This Web-based activity, available on the internet and via teleconference, is conveniently scheduled to enable clinicians from all over the US to participate in a discussion with national thought leaders. The program includes an overview of the disease state and reviews important treatment considerations when caring for this disease. Each session includes the presentation of challenging cases that highlight key issues in treating atopic dermatitis in adults and children and will address various available agents and management strategies. Each teleconference concludes with a live 15-minute question and answer session between the faculty and conference participants.
|
Atopic dermatitis (AD) is a chronic relapsing, pruritic, inflammatory skin condition. It affects up to 20% of children and 1% to 3% of adults and is commonly associated with personal or family history of other atopic disease. While the pathogenesis of AD is not completely understood, it is believed to be multifactorial in nature caused by interactions between the body’s immune system, genetics, the environment, and skin barrier dysfunction. To successfully manage the condition, the approach to
AD treatment should be multimodal and address both skin inflammation and barrier dysfunction. Topical corticosteroids have been the mainstay of therapy for treatment of AD-associated inflammation.
This program will enable dermatologists to develop strategies for tailoring individual treatment regimens. The different classes of topical corticosteroids will be identified and issues such as safety, effectiveness, and limitations of the agents will be discussed.
|
|
The overall learning objectives of this program are to:
- Describe the similarities and differences and discuss the current and emerging evidence regarding the use of currently available steroid-containing topical agents in the management of atopic dermatitis
- Differentiate clinical severity levels as they relate to atopic dermatitis and identify and select appropriate topical interventions to achieve prompt disease remission and minimize flares
- Identify evidence-based selection of topical agents based on safety and efficacy profiles, patient characteristics and age, via case-based discussions
- Establish a continuum of care for the management of atopic dermatitis that optimizes treatment selection and maximizes patient outcomes
This activity has been developed for dermatologists and other healthcare professionals who treat patients with atopic dermatitis.
|
|
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Penn State College of Medicine and SynerMed® Communications. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The archived teleconference
will be available as an enduring activity for anytime playback after the final lecture.
Released: March 2008 and Expires: March 31, 2009.
|
|
Penn State College of Medicine designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should only claim credit commensurate with
the extent of their participation in the activity.
It is our policy to ensure balance, independence, objectivity, and scientific rigor in all of our educational programs. Faculty and course directors have disclosed relevant financial relationships with commercial companies, and Penn State has a process in place to resolve any conflict of interest. Complete faculty disclosure will be provided to program participants prior to the beginning of the activity.
|